Trials / Not Yet Recruiting
Not Yet RecruitingNCT06952296
Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Abbott · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
The study is an observational, multicenter, prospective, single arm study to evaluate the efficacy of dydrogesterone in endometriosis-related pain (EAP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone | The duration of treatment with dydrogesterone is determined by the physician before inclusion in the study and will last for 6 menstrual cycles ("Cycle" used in the protocol refers to menstrual cycle. 1 cycle is 28 days on average) |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Source: ClinicalTrials.gov record NCT06952296. Inclusion in this directory is not an endorsement.